Alternatively, assessing DNA repair capacity via assays of particular enzymes (DNA polymerase β “β pol” and XPG or ERCC5) involved in definite zinc finger protein-modulated repair pathways, with the use of protein extracts from human tissues or cells, might be useful for partially evaluating cancer risk [98,99]. This evidence concerns the gene ZNF146 and cancer.